Inactive Instrument

Insiders Cellectar Biosciences Inc Nasdaq

Equities

US15117F3029

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

Cellectar Biosciences Hires Dr. Andrei Shustov as New Senior Vice President, Medical	23-02-15	CI
Cellectar Biosciences, Inc. Announces Appointment of Shane Lea as Chief Commercial Officer	22-11-30	CI
Femasys Names Dov Elefant as CFO	22-02-24	MT
Cellectar Biosciences Appoints Chad Kolean Chief Financial Officer, Promotes Jarrod Longcor to Chief Operating Officer	22-02-23	MT
Cellectar Biosciences Appoints Jarrod Longcor as Chief Operating Officer	22-02-23	CI
Cellectar Biosciences Appoints Chad Kolean as Chief Financial Officer	22-02-23	CI
Kazia Therapeutics Names Chief Medical Officer; Shares Rise 3%	21-11-14	MT
Cellectar Biosciences, Inc. Announces Executive Changes	21-11-02	CI
Cellectar Biosciences, Inc. Announces the Election of Dr. Asher Alban Chanan-Khan to Its Board of Directors	21-06-24	CI
Cellectar Biosciences, Inc. Announces Resignation of Stephen Hill	21-05-03	CI
Cellectar Biosciences, Inc. Appoints John Friend as Chief Medical Officer	20-07-01	CI
Cellectar Biosciences, Inc. Appoints Igor Grachev as Chief Medical Officer	20-01-07	CI
Cellectar Biosciences, Inc. Appoints Dov Elefant as Chief Financial Officer Effective as of September 10, 2019	19-08-15	CI
Cellectar Biosciences, Inc. Appoints Charles T. Bernhardt as Interim Chief Financial Officer, Effective March 9, 2019	19-03-08	CI
Cellectar Biosciences, Inc. Announces the Resignation of Brian M. Posner as Chief Financial Officer, Effective March 8, 2019	19-02-15	CI
Cellectar Biosciences, Inc. Announces Resignation of John E. Friend Ii as Vice President and Chief Medical Officer, Effective November 27, 2018	18-11-16	CI
Cellectar Biosciences Appoints Brian M. Posner as Vice President and Chief Financial Officer	18-04-04	CI
Cellectar Biosciences, Inc. Promotes Jarrod Longcor to Chief Business Officer	17-09-18	CI
Cellectar Biosciences, Inc. Announces Management Changes	17-08-18	CI
Cellectar Biosciences, Inc. Appoints John Friend, II, M.D. as Vice President and Chief Medical Officer Effective April 17, 2017	17-04-12	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Cellectar Biosciences Inc Nasdaq

Equities

US15117F3029

Insiders

Filters